Skip to main content
. 2016 Nov 5;129(21):2567–2575. doi: 10.4103/0366-6999.192776

Figure 5.

Figure 5

(a) Amplification of kinetic curves of BMP-2 mRNA expression; (b) amplification of kinetic curves of GAPDH mRNA expression; (c) comparison of BMP-2 mRNA expression in the control to that of the treatment group at 1, 3 days, 1, 2, 4, 6, and 8 weeks after treated with roughly focused ESWT. BMP-2 mRNA expression in the treatment group and in the control group, P < 0.05 (data not shown) (note: BMP-2 mRNA expression at 1 day after roughly focused ESWT was normalized to 1). ESWT: Extracorporeal shock waves therapy; BMP-2: Bone morphogenetic protein-2; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; mRNA: Messenger RNA.